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Increasing cellular glucose uptake is a funda-
mental concept in treatment of type 2 diabetes,
whereas nutritive calorie restriction increases
life expectancy. We show here that increased
glucose availability decreases Caenorhabditis
elegans life span, while impaired glucose me-
tabolism extends life expectancy by inducing
mitochondrial respiration. The histone deacety-
lase Sir2.1 is found here to be dispensable for
this phenotype, whereas disruption of aak-2,
a homolog of AMP-dependent kinase (AMPK),
abolishes extension of life span due to impaired
glycolysis. Reduced glucose availability pro-
motes formation of reactive oxygen species
(ROS), induces catalase activity, and increases
oxidative stress resistance and survival rates,
altogether providing direct evidence for a hith-
erto hypothetical concept namedmitochondrial
hormesis or ‘‘mitohormesis.’’ Accordingly,
treatment of nematodes with different antioxi-
dants and vitamins prevents extension of life
span. In summary, these data indicate that
glucose restriction promotes mitochondrial
metabolism, causing increased ROS formation
and cumulating in hormetic extension of life
span, questioning current treatments of type 2
diabetes as well as the widespread use of anti-
oxidant supplements.
INTRODUCTION
Reduced uptake of nutritive calories, termed calorie re-
striction (CR), is a long-standing intervention to extend
life span in multicellular eukaryotes, including mammals
(Weindruch and Walford, 1988). While it is currently
unknown whether such interventions are capable of ex-
tending life span in humans, CR has recently been linked
to desirable metabolic alteration in this species (Heilbronn
et al., 2006). The idea that life span might be dependent on
metabolic flux dates back to 1908, when Max Rubner280 Cell Metabolism 6, 280–293, October 2007 ª2007 Elseviersuggested that maximum life span is inversely proportional
to the amount of nutritive energy metabolized (Rubner,
1908). This hypothesis was extended in 1928 by Raymond
Pearl, who proposed that an increased metabolic rate
would decrease life span in eukaryotes (Pearl, 1928).
Mechanistically, metabolism-induced production of reac-
tive oxygen species (ROS) was introduced as the under-
lying cause, suggesting that increased mitochondrial
metabolism would induce ROS formation and subse-
quently cause cellular and systemic damage cumulating
in reduced life expectancy (Harman, 1956).
Recently, increasing evidence has emerged that the op-
posite might apply: It has been repeatedly hypothesized
that induction of mitochondrial metabolism might cause
a positive response to increased formation of ROS and
other stressors, leading to a secondary increase in stress
defense, cumulating in reduced net stress levels and pos-
sibly extended life span (Houthoofd et al., 2002b; Johnson
et al., 2002; Kharade et al., 2005; Sinclair, 2005; Vanflete-
ren, 1993; Zarse et al., 2007). These interpretations are
supported by the fact that exercise increases ROS forma-
tion (Chevion et al., 2003), while physical activity has been
shown to extend life span in humans (Lindsted et al., 1991;
Manini et al., 2006) independently of body mass (Hu et al.,
2004). Accordingly, recent evidence suggests that anti-
oxidant food supplements may decrease life span in
humans (Bjelakovic et al., 2007).
In westernized countries, glucose represents a key die-
tary component since the most commonly ingested sugar,
sucrose, contains equimolar amounts of glucose and fruc-
tose (Popkin and Nielsen, 2003). Specifically, in Ameri-
cans, added dietary sugar accounts today for 15.8% of
daily calorie intake (Malik et al., 2006). Nevertheless, it is
a matter of debate whether glucose and other carbo-
hydrates have a relevant effect on disease burden and
mortality in humans, and experimental data in mammals
warrant further investigation.
To directly address the putative role of glucose metab-
olism in a multicellular eukaryote in regards to life expec-
tancy, we exposed the nematode Caenorhabditis elegans
to a chemical inhibitor of glycolysis, producing a metabolic
state resembling that of dietary glucose restriction (Ingram
et al., 2006). We observed a significant AAK-2-dependent
extension of life span in states of impaired glucose
metabolism, induction of mitochondrial respiration, andInc.
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Life-Span Extension by ROS-Dependent MitohormesisFigure 1. Increased Life Span Due to Increased Respiration in States of Impaired Glucose Metabolism
(A) Release of 14C-labeled CO2 from radioactively labeled D-glucose in control- and 2-deoxy-D-glucose (DOG)-treated nematodes. Black bars indi-
cate control scores; white bars indicate scores of animals treated with DOG (also applies to Figures 1F and 1G, Figures 3E and 3F, and Figures S1A
and S2). In this and all subsequent figures, error bars represent SEM; *p < 0.05, **p < 0.01.
(B) Preliminary screen of wild-type nematodes treated with different concentrations of DOG throughout their lifetime. Survival at three different time
points is depicted; white bars indicate survival at day 15, gray bars indicate survival at day 20, and black bars indicate survival at day 25. Only dead
animals were scored; no censoring events were incorporated in this analysis.
(C) Life-span assays for wild-type N2 C. elegans fed with live OP50-i bacteria and permanently treated with DOG.C indicates untreated control;,
indicates animals with the respective treatment as indicated (also applies to Figures 1D and 1E, Figures 3G and 3H, and Figure S2D).
(D) Life-span assays for wild-type N2 C. elegans fed growth-arrested OP50 bacteria and permanently treated with DOG.
(E) Life-span assays for wild-type N2 C. elegans fed live OP50 bacteria and treated with DOG for 6 days only.
(F) Triglyceride content after 2, 24, and 48 hr of DOG administration for wild-type C. elegans.
(G) Oxygen consumption after 2, 24, and 48 hr following initiation of DOG treatment for wild-type C. elegans.subsequently increased oxidative stress, which can be
abolished by pretreatment with different antioxidants,
supporting a process to be termed mitochondrial horme-
sis or ‘‘mitohormesis.’’
RESULTS AND DISCUSSION
Impaired Glycolysis in C. elegans Due to
Treatment with 2-Deoxy-D-Glucose
To investigate the potential role of impaired glucose
metabolism in life span in a multicellular eukaryote, we
exposed adult C. elegans to 2-deoxy-D-glucose (DOG) at
5 mM concentration. DOG, which is efficiently phosphory-
lated by hexokinase but cannot be further metabolized,Cell Mleads to a specific blockade of glucose metabolism and
glycolysis, while breakdown of other nutrients remains
unaffected (Sols and Crane, 1954). Accordingly, when
maintained on DOG, nematodes almost completely lost
the ability to oxidize exogenous, radioactively labeled glu-
cose, as shown by impaired production of uniformly 14C-
labeled carbon dioxide (Figure 1A). When maintained on
DOG, nematodes showed reduced fertility and a decrease
in total progeny production (see Figure S1A in the Supple-
mental Data available with this article online), both of which
are typical for states of extended longevity (Houthoofd
et al., 2002b). We next aimed to establish whether chemi-
cally altered glucose, as in the case of DOG, is readily
transported into nematodes. To test this possibility, weetabolism 6, 280–293, October 2007 ª2007 Elsevier Inc. 281
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Life-Span Extension by ROS-Dependent Mitohormesisexposed worms to 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-
yl)amino)-2-deoxyglucose (NBDG), which accumulated
mainly in the gut but also appeared to be detectable, al-
though to a much lesser extent, in other regions of the nem-
atode (Figures S1B–S1E). To further investigate the tran-
scriptional results of DOG treatment, nematodes were
maintained on this compound for 48 hr, and RNA was ex-
tracted and analyzed by the Affymetrix C. elegans RNA
chip. These analyses revealed an unambiguous induction
of energy metabolism, and especially levels of transcripts
encoding proteins involved in lipid storage and transport
as well as fatty acid oxidation were found to be significantly
upregulated. Interestingly, a number of genes involved in
mitochondrial energy conversion, namely subunits of the
F1F0-ATPase complex, showed increased expression
(see grouped summary in Table S1). We identified further
pathways of potential interest to be regulated, which
have been summarized in the Table S1 and are additionally
provided as a complete list of all regulated genes in Table
S2. Of note, a large group of transcripts encoding collagen
or collagen-like proteins displayed clear downregulation
after DOG exposure (Table S1). Also, two additional
groups, transthyretin-like proteins and carbohydrate-
binding proteins (the latter of which are also known as lec-
tins), were downregulated in a remarkably constant fash-
ion (Table S1). Additionally, another group of genes was
identified during our analysis that has been predicted to in-
teract with each other in a previous study (Zhong and
Sternberg, 2006) integrating a meta-analysis of genetic in-
teractions in different species (Table S1).
Reduced Glucose Metabolism Extends Life Span
Nematodes were exposed to different concentrations of
DOG, and preliminary survival rates at different time points
showed a typical bell-shaped curve (Figure 1B). Nema-
todes maintained on their usual food source, live E. coli,
showed a 25% extension of maximum life span and 17%
extension of mean life span (Figure 1C; Table 1) when main-
tained on DOG. To exclude the possibility that DOG is me-
tabolized by E. coli, resulting in nonspecific alterations of
phenotypes, experiments were repeated with nematodes
maintained on growth-arrested E. coli. Maximum life span
was similarly increased by 23% and mean life span by
13% under these conditions (Figure 1D; Table 1).
To further evaluate whether life span could be extended
by limiting the duration of DOG exposure, we placed nema-
todes on DOG-containing plates for the first 6 days of early
adult lifeonly; thereafter, theywere maintainedonDOG-free
media.Asshown inFigure1E, thisshort-termtreatment was
sufficient to extend the worms’ life span (see also Table 1).
Lastly, we wondered whether impaired availability of
glucose could lead to increased metabolism of triglycer-
ides, supported by a wide body of evidence in mammals
(Malik et al., 2006). We observed a significant reduction
of body fat in nematodes exposed to DOG (Figure 1F),
suggesting increased b oxidation of fatty acids in states
of glucose restriction. This is supported by our initial ob-
servation on the regulation of lipid metabolism-related
transcripts (Table S1).282 Cell Metabolism 6, 280–293, October 2007 ª2007 ElsevierTaken together, these findings suggest that both short-
term and continuous impairment of glucose metabolism
extends C. elegans life span, a conclusion supported by
previous findings suggesting that disruption of certain gly-
colytic genes may extend life span in nematodes (Hamil-
ton et al., 2005; Hansen et al., 2005; Lee et al., 2003b).
Reduced Glucose Metabolism
Induces Respiration
In the unicellular eukaryote Saccharomyces cerevisiae,
glucose restriction has been shown to extend life span
by inducing respiration in a proposedly sirtuin-dependent
fashion (Lin et al., 2002). Sirtuins are histone deacetylases
that have been shown to extend C. elegans life span in
states of overexpression where respiration has not been
quantified (Tissenbaum and Guarente, 2001). Houthoofd
and colleagues (2002a, 2002b) have found normal
or even increased metabolic rates in genetically or envi-
ronmentally food-deprived nematodes. The above-
mentioned findings in S. cerevisiae have recently been
challenged by demonstration of glucose-deprivation-
dependent extension of life span in S. cerevisiae lacking
mitochondrial DNA and hence presumably devoid of
respiratory capacity (Kaeberlein et al., 2005).
Here, we quantified mitochondrial respiration in C.
elegans in states of impaired glucose metabolism and
observed a significant induction of oxygen consumption
in nematodes exposed to DOG in comparison to control
animals (Figure 1G). This suggests thatC. elegans induces
mitochondrial metabolism in response to impaired glyco-
lysis, consistent with previously published findings for
glucose-independent states of calorie restriction in
C. elegans (Houthoofd et al., 2002a, 2002b) and glucose
restriction in S. cerevisiae (Lin et al., 2002). Moreover,
these findings are supported by recent findings suggest-
ing a positive correlation of respiratory rate and life span
in C. elegans independent of calorie restriction (Zarse
et al., 2007).
Other Modifications of Glucose Metabolism
Correspondingly Alter Life Span and Respiration
To exclude the remote possibility that alterations in life
span following DOG treatment are caused by mechanisms
other than impaired glycolysis, we tested whether treat-
ment of C. elegans with RNA interference (RNAi) directed
against a glycolytic enzyme, glucose phosphate isomer-
ase (gpi-1), would exert a phenotype similar to that ob-
served after DOG treatment. Of note, GPI-1 is an enzyme
known to be competitively inhibited by DOG treatment.
Consistent with previously published data (Hamilton
et al., 2005; Hansen et al., 2005; Lee et al., 2003b), we
observed increased life span in states of impaired gpi-1
expression that presumably mimic metabolic effects of
DOG (Figure 2A; Table 1). As observed for states of
DOG treatment (Figure 1G), impaired gpi-1 expression ac-
cordingly increased respiration in C. elegans (Figure 2B).
We then questioned whether increased availability of
glucose would conversely decrease life span in worms
by impairing respiration. When nematodes were exposedInc.
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Life-Span Extension by ROS-Dependent MitohormesisTable 1. Summary of Individual Life-Span Experiments
Max Life Span
in Days ± SEM
Mean Life Span
in Days ± SEM n
p Value versus
Control
N2 control 27.9 ± 0.6 17.7 ± 0.4 7
N2 5.0 mM DOG (full) 35.0 ± 1.7 20.7 ± 0.5 5 <0.0001
N2 5.0 mM DOG (6 days treatment) 34.3 ± 1.3 20.6 ± 0.7 4 <0.0001
N2 NAC (full) 29.0 ± 1.0 16.0 ± 0.1 2 n.s. (0.4792)
N2 NAC (9 days treatment) 29.5 ± 1.5 17.3 ± 0.2 2 n.s. (0.2613)
N2 NAC (full)/DOG (full) 28.5 ± 1.5 16.0 ± 1.2 2 n.s. (0.1745)
N2 NAC (full)/DOG (6d) 29.5 ± 0.5 15.8 ± 0.3 2 n.s. (0.1257)
N2 NAC (9 days)/DOG (full) 34.5 ± 0.5 18.8 ± 0.5 2 <0.0001
N2 NAC (9 days)/DOG (6 days) 27.5 ± 1.5 17.2 ± 0.6 2 n.s. (0.3510)
N2 DOG postreproductive (full) 35.0 20.4 1 <0.0001
N2 control (arrested bacteria) 33.3 ± 0.8 23.2 ± 0.3 6
N2 5.0 mM DOG (full + arrested bacteria) 41.0 ± 1.0 26.2 ± 1.7 3 <0.0001
N2 5.0 mM D-glucose (full + arrested bacteria) 32.7 ± 0.6 21.9 ± 0.5 3 <0.0001
N2 50.0 mM D-glucose (full + arrested bacteria) 32.7 ± 0.6 21.4 ± 0.5 3 <0.0001
N2 control (+ethanol) 25.0 17.8 1
N2 5 mM DOG (full + ethanol) 32.0 20.9 1 <0.0001
N2 vitamin C (full + ethanol) 26.0 19.0 1 n.s. (0.3050)
N2 vitamin C (full)/DOG (full + ethanol) 26.0 18.4 1 n.s. (0.7136)
N2 trolox (full + ethanol) 26.0 18.3 1 n.s. (0.6160)
N2 trolox (full)/DOG (full + ethanol) 28.0 18.4 1 n.s. (0.5363)
AAK-2 control 21.2 ± 1.1 14.9 ± 0.5 4
AAK-2 DOG (full) 19.5 ± 1.5 13.8 ± 0.1 2 0.0190
AAK-2 DOG (6 days) 22.5 ± 0.5 14.0 ± 0.6 2 n.s. (0.0739)
RNAi control (vector L4440) 25.0 17.2 1
RNAi gpi-1 28.0 20.5 1 <0.0001
sir2.1 control (live bacteria) 26.0 19.1 1
sir2.1 DOG (6 days) 29.0 22.5 1 0.0014
sir2.1 DOG (full) 30.0 23.3 1 <0.0001
sir2.1/rrf-3 control (live bacteria) 24.0 16.8 1
sir2.1/rrf-3 DOG (6 days) 26.0 18.9 1 0.0002
sir2.1/rrf-3 DOG (full) 27.0 20.0 1 <0.0001
Summary of maximum and mean life spans and statistical analysis (p values) for life-span experiments, including all strains and
different treatments displayed in Figures 1C–1E, Figures 2A and 2C, Figures 3A, 3B, 3G, and 3H, Figures 5A–5C, and Figures
S2A–S2D. Maximum and mean life spans summarize means of n independent experiments. n.s. = not significant.to different concentrations of D-glucose (5 and 50 mM),
they showed a significant decrease in mean life expec-
tancy (Figure 2C; Table 1) that was paralleled by increased
relative triglyceride content (Figure 2D) and reduced
respiratory activity (Figure 2E). Hence, increased glucose
availability displayed opposite effects as compared to the
observations reported for nematodes treated with DOG,
thereby not only providing further support for our hypoth-
esis but also emphasizing the detrimental effect of
glucose on the mitochondria in eukaryotic organisms.Cell MThe Histone Deacetylase Sir2.1 Is Dispensable
for C. elegans Life-Span Extension
It has been previously shown for states of glucose restric-
tion in S. cerevisiae that the histone deacetylase Sir2 is
required for extension of replicative life span in yeast (Lin
et al., 2000; Lin et al., 2002). We accordingly hypothesized
that this protein might be responsible for extension of life
span in C. elegans. Unexpectedly, we found that DOG
treatment was capable of extending life span in two
genetically different strains lacking Sir2.1, named sir2.1etabolism 6, 280–293, October 2007 ª2007 Elsevier Inc. 283
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Life-Span Extension by ROS-Dependent MitohormesisFigure 2. Modulation of Glycolytic
Metabolism Is Inversely Correlated with
Life Expectancy
(A and B) Life expectancy (A) and oxygen con-
sumption (B) inC. elegans after RNAi-mediated
reduction of glucose phosphate isomerase
(gpi-1) expression. C indicates nematodes
fed control RNAi bacteria harboring the control
RNAi vector L4440; , indicates animals fed
RNAi bacteria harboring the gpi-1 RNAi-
encoding plasmid. Black bar indicates control
RNAi; white bar indicates gpi-1 RNAi-treated
animals.
(C–E) Life expectancy (C), triglyceride content
(D), and oxygen consumption rate (E) following
administration of various D-glucose concen-
trations. C and black bars indicate controls;
6 and gray bars indicate 5 mM glucose; ,
and open bars indicate 50 mM glucose.(Figure 3A; Table 1) and sir2.1/rrf-3 (Figure 3B; Table 1),
surprisingly suggesting that Sir2.1 signaling is not required
for life-span extension in states of glucose restriction in
C. elegans.
The C. elegans Homolog of AMPK, AAK-2,
Is Required for Life-Span Extension
It has previously been shown that AAK-2, the C. elegans
homolog of mammalian AMP-dependent kinase (AMPK)
(Curtis et al., 2006), may play a role in life-span extension
in response to various short-term stressors (Apfeld et al.,
2004). Phosphorylation of AMPK at serine 172, and hence
activity of this kinase, is induced by increasing intracellular
levels of AMP and accordingly by decreasing levels of ATP
(Kahn et al., 2005), both of which are to be anticipated in
states of calorie restriction. Moreover, AMPK has been
shown to specifically induce mitochondrial metabolism
in mammalian cells (Kahn et al., 2005). Given the impor-
tance of both glycolysis and mitochondrial metabolism
in providing sufficient amounts of ATP, we questioned
whether phosphorylation of AAK-2 might be altered in
states of DOG exposure and hence impaired glycolysis.
We observed increased abundance of the phosphorylated
form of AAK-2/AMPK following short-term exposure to
DOG, while this induction became less pronounced after
long-term exposure (Figure 3C; percent increase after284 Cell Metabolism 6, 280–293, October 2007 ª2007 Elseviernormalization to a-tubulin: 2 hr, 110%; 24 hr, 24%;
48 hr, 21%).
We subsequently quantified the abundance of the phos-
phorylated form of AAK-2/AMPK in nematodes treated
with high glucose concentrations (Figure 3D, lanes 1–3)
and animals fed with RNAi bacteria directed against
gpi-1 (Figure 3D, lanes 4 and 5). While administration of
high glucose concentrations reduced the abundance of
phosphorylated AAK-2/AMPK (Figure 3D, columns 1–3;
percent decrease after normalization to a-tubulin: 5 mM,
71%; 50 mM, 41%), RNAi directed against gpi-1 mildly in-
creased abundance of the phosphorylated form (Fig-
ure 3D, lanes 4 and 5; 27% increase after normalization
to a-tubulin), which altogether provides a phosphorylation
pattern resembling that of nematodes treated with DOG
(Figure 3C). Importantly, phosphorylated AAK-2 protein
was not detectable in the aak-2 mutant strain in either
the basal state (Figure 3C, lane 1) or the DOG-exposed
state (data not shown). Taken together, these findings
suggest that presence of AAK-2/AMPK is required for
life-span extension in C. elegans under conditions of im-
paired glucose metabolism.
Since AMPK has been linked to altered b oxidation of
fatty acids in mammalian systems (Kahn et al., 2005), we
analyzed triglyceride content in nematodes lacking
AAK-2 in the presence and absence of DOG (Figure 3E).Inc.
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Life-Span Extension by ROS-Dependent MitohormesisFigure 3. Increased Life Span in States of Glucose Restriction Requires AAK-2, the C. elegans AMPK Homolog
(A) Life-span analysis of the sir2.1 mutant strain.C indicates control animals;6 indicates animals exposed to DOG for 6 days;, indicates animals
exposed to DOG continuously (also applies to [B]).
(B) Life-span analysis of the sir2.1/rrf-3 mutant strain.
(C) Abundance of the phosphorylated form of AAK-2/AMPK is increased after 2, 24, and 48 hr of DOG treatment (columns 2–7, upper row; percent
increase versus control: 2 hr, 110%; 24 hr, 24%; 48 hr, 21%) in the wild-type N2 nematode. No phosphorylated protein could be detected for the
aak-2-deficient strain (column 1, upper row). Thirty micrograms of protein lysate was loaded on each column; a-tubulin was used as a loading control
and for signal normalization (lower row).
(D) Abundance of the phosphorylated form of AAK-2/AMPK upon exposure to high glucose concentrations after 48 hr of treatment (columns 1–3;
percent decrease versus control: 5 mM, 71%; 50 mM, 41%) and after RNAi treatment directed against gpi-1 (columns 4 and 5; percent increase ver-
sus control: 27%).
(E) Triglyceride content in aak-2 mutant animals treated with DOG for 2, 24, and 48 hr.
(F) Oxygen uptake in the aak-2-deficient strain after 2, 24, and 48 hr of treatment with DOG.
(G) Life span of the aak-2-deficient strain fed live OP50-i bacteria and permanently exposed to DOG.
(H) Life span of the aak-2-deficient strain fed live OP50-i bacteria and exposed to DOG for 6 days.Cell Metabolism 6, 280–293, October 2007 ª2007 Elsevier Inc. 285
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fat content (Figure 3E versus Figure 1F), but no further
reduction was achieved by applying DOG (Figure 3E).
Accordingly, induction of oxygen consumption as ob-
served in wild-type N2 worms following DOG exposure
was completely abolished in aak-2 mutant nematodes
(Figure 3F). As the aak-2 mutant strain displayed a shorter
life expectancy than the wild-type strain, we questioned
whether overall oxygen consumption rates might be lower
in this strain. However, we observed only a slight and
nonsignificant trend toward reduced respiration in aak-2
mutant nematodes as compared to wild-type worms
(data not shown).
If induction of respiration is required for extension of life
span, life expectancy of nematodes lacking AAK-2 protein
should not increase following glucose restriction. Indeed,
DOG treatment of aak-2 mutant nematodes failed to
increase life span, in contrast to observations in wild-
type N2 worms (Figures 1C–1E; Table 1) and sir2-deficient
worms (Figures 3A and 3B), but rather showed a small but
significant decrease in mean life span for states of contin-
uous DOG treatment (Figure 3G; Table 1). Short-term
DOG exposure for 6 days (performed as described above)
similarly failed to produce any extension of life span as ob-
served in wild-type worms (Figure 1E), but in contrast to
continuous DOG treatment (Figure 3G) showed no signif-
icant difference in regards to life span in aak-2-deficient
nematodes (Figure 3H; Table 1), suggesting that putative
toxicity of DOG is unlikely to be involved in the phenotype
observed. Taken together, these findings suggest that
induction of respiration following glucose restriction is
initiated by AAK-2 and that this kinase is required for
extension of life span in glycolytically impaired C. elegans,
while Sir2 appears to be dispensable.
Reduced Glucose Metabolism Induces ROS
Formation and Subsequently Stress Resistance
Induction of respiration is commonly accepted to cause
increased formation of ROS as an inevitable by-product
of increased electron transfer within the respiratory chain
(Dro¨ge, 2002; Rea and Johnson, 2003). ROS are assumed
to be detrimental to many biological processes (Harman,
1956). In contrast, it has been hypothesized at least in
the case of glucose-restricted S. cerevisiae that ROS
may induce enzymes capable of oxygen radical detoxifi-
cation, ultimately leading to increased defense capacity
against ROS (Kharade et al., 2005). Whether this process
occurs in eukaryotes in a similar manner in regards to life-
span extension has not been fully elucidated (Ingram et al.,
2006; Johnson et al., 2002; Sinclair, 2005; Vanfleteren,
1993). Nevertheless, it has been suggested for both
C. elegans (Houthoofd et al., 2002a, 2003; Johnson
et al., 2002) as well as mice (Speakman, 2005; Speakman
et al., 2004) that similar mechanisms, i.e., paradoxical in-
duction of stress resistance in states of increased mito-
chondrial activity, might apply to multicellular eukaryotes
for reasons widely unresolved. Concurrently, as long-
term as well as short-term treatment with DOG is sufficient
to increase life span, our current findings are in accord286 Cell Metabolism 6, 280–293, October 2007 ª2007 Elseviewith the hormesis theory of aging, hormesis being defined
as a short-lasting and nonlethal stressor that induces the
stress response mechanisms of an organism and thereby
increases not only stress resistance but also overall life
expectancy (Masoro, 2006; Rattan, 2001; Southam and
Ehrlich, 1943). Also, hormesis has been observed in C.
elegans under different conditions of stress such as direct
oxidative and thermal stress (Cypser and Johnson, 2002).
Therefore, we first tested whether impairing glycolysis
indeed might induce ROS formation in C. elegans. In
states of exposure to DOG for 48 hr, nematodes showed
an approximately 3-fold increase in ROS formation (as
quantified by DCF fluorescence; Kampko¨tter et al.
[2007]) in comparison to untreated worms (Figure 4A, left
pair of bars). Not surprisingly, pretreatment of nematodes
with N-acetylcysteine (NAC), a membrane-permeable glu-
tathione precursor known to ameliorate the effects of ROS
by mimicking the radical-scavenging potential of reduced
glutathione, significantly decreased ROS formation in
DOG-treated nematodes (Figure 4A, right pair of bars).
To see whether this induction of ROS formation due to
DOG treatment might exert hormetic effects on C. ele-
gans, we next quantified enzymes known to detoxify
ROS in eukaryotic systems, namely superoxide dismutase
(SOD), glutathione peroxidase (GPX), and catalase (CAT).
While no induction of SOD or GPX activity was observed
at four time points evaluated (data not shown), CAT activ-
ity was found to be significantly increased in nematodes
treated with DOG for 6 days (Figure 4B), though no signif-
icant alterations in CAT activity were observed after 2, 24,
and 48 hr (data not shown). Hence, restriction of glucose
metabolism might induce ROS defense by causing a sec-
ondary increase in CAT activity (not observed before 144
hr of treatment) in C. elegans following a primary increase
in ROS formation (observed as early as after 48 hr of treat-
ment). These findings suggest that increased antioxidant
defense capacity (Figure 4B) is a consequence of in-
creased ROS formation (Figure 4A) in states of impaired
glucose metabolism.
Next, we exposed DOG-treated nematodes to sodium
azide or paraquat, both of which are known to act as mito-
chondrial stressors and to be capable of inducing mito-
chondrial ROS formation. Treatment was initiated 6 days
after DOG exposure began. DOG-treated worms showed
significantly increased survival rates when exposed to
paraquat (Figure 4C) or sodium azide (Figure 4D), demon-
strating increased stress resistance despite elevated respi-
ratory activity (Figure 1G) in states of impaired glycolysis.
Reactive Oxygen Species Are Required
for Increase of Life Span
To investigate the possibility that induction of stress resis-
tance in states of glucose restriction (Figures 4C and 4D) is
dependent on DOG-induced ROS formation (Figure 4A),
we again pretreated nematodes with NAC. As shown
above, such pretreatment significantly reduced the induc-
tion of ROS following DOG exposure (Figure 4A) and, in
parallel, completely abolished the previously observed
(Figures 4C and 4D) increase in stress resistance, whichr Inc.
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tive Oxygen Species Promotes Stress
Resistance in States of Glucose Restric-
tion
(A) Relative formation of reactive oxygen spe-
cies (ROS) after 48 hr of exposure to DOG
with and without pretreatment with N-acetyl-
cysteine (NAC). Black bar indicates control
animals; white bar indicates DOG-exposed an-
imals; dark gray bar indicates animals treated
with NAC alone; light gray bar indicates expo-
sure to NAC and DOG.
(B) Catalase activity in untreated control ani-
mals and animals after 6 days of DOG expo-
sure. Black bar indicates control animals; white
bar indicates DOG-treated animals.
(C and D) Survival of nematodes after 6 days of
pretreatment with DOG on NGM plates addi-
tionally containing 50 mM paraquat (C) and
1 mM sodium azide (D).C indicates untreated
control;, depicts nematodes treated perma-
nently with DOG.
(E and F) Survival of nematodes maintained on
NAC during development and 6 days of pre-
treatment with DOG on NGM plates additionally
containing 50 mM paraquat (E) or 1 mM sodium
azide (F).C indicates untreated control nema-
todes; , indicates animals treated with DOG
only; B indicates animals treated with NAC
only; 6 indicates animals treated with NAC
and DOG.was now absent in states of both paraquat (Figure 4E) as
well as sodium azide exposure (Figure 4F). These findings
indicate that increased formation of ROS in glycolytically
impaired worms is required for the hormetic induction of
stress resistance.
Since pretreatment with the antioxidant NAC decreased
both ROS formation and acute resistance to paraquat and
sodium azide, we questioned whether the extension of life
span induced by DOG (Figures 1C–1E) might be reduced
by NAC treatment as well. We first observed that treat-
ment of nematodes with NAC alone had no significant in-
fluence on life span (Figure 5A; Table 1), suggesting that
this antioxidant is dispensable for and incapable of life-
span extension in C. elegans.
More importantly, we next observed that pretreatment
of nematodes with NAC completely abolished the effects
of DOG on life-span extension under various combina-
tions of short- and long-term exposure (Figure 5A; Table
1; Figures S2A–S2C), suggesting that induction of ROS
must exceed a threshold (Figure 4A) to increase life expec-
tancy in worms in states of impaired glycolysis. Of note,
removal of NAC after 9 days of treatment in states of sus-
tained DOG treatment failed to prevent extension of life
span by glucose restriction (Table 1; Figure S2C). Simi-
larly, initiation of DOG treatment in a later, postfertile
period of the C. elegans life cycle was still capable of in-
creasing life span in states of DOG exposure (Table 1;
Figure S2D). To rule out the possibility that effects of
NAC other than its ROS-scavenging properties might be
responsible for the phenotype observed, we subsequentlyCellperformed life-span experiments with two other well-
established antioxidants, ascorbic acid (vitamin C) (Fig-
ure 5B) and the a-tocopherol (vitamin E) derivative trolox
(Figure 5C). As observed with NAC treatment, administra-
tion of either antioxidant followed by DOG abrogated any
extension of life span (Figures 5B and 5C), while the re-
spective antioxidant alone had no significant effect on
life expectancy (Figures 5B and 5C).
These latter findings tentatively suggest that the wide-
spread use of antioxidants as human food supplements
may exert undesirable effects, i.e., decreased cellular
and possibly impaired systemic stress resistance that
may decrease life expectancy in higher eukaryotes.
Mitohormetic Control of Eukaryotic Life Span
Glycolysis is a biochemical process generating ATP with-
out requiring gaseous oxygen, in contrast to the process
of mitochondrial respiration. Inhibition of this pathway by
DOG causes a reduction of glycolytic ATP synthesis
from glucose (Sols and Crane, 1954). Consistent with
this, we observed a mild decrease in ATP levels after 48
hr of DOG treatment (data not shown). Our findings sug-
gest that C. elegans compensates for decreased levels
of glycolytic ATP by increased production of mitochon-
drial ATP, as reflected by increased oxygen consumption
in states of glucose deprivation (Figure 1G). This meta-
bolic shift from glycolytic to mitochondrial metabolism is
initiated by AAK-2 (Figures 3C–3H). Disruption of aak-2
has previously been shown to reduce life span in C. ele-
gans, presumably due to impaired capacity of oxidativeMetabolism 6, 280–293, October 2007 ª2007 Elsevier Inc. 287
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2004). Accordingly, we show here that AAK-2 is required
to induce respiration, and hence oxidative ATP supply,
in states of impaired glycolysis and glucose deprivation.
These findings are supported by previous studies poten-
tially linking carbohydrate metabolism to C. elegans life
span (Hamilton et al., 2005; Hansen et al., 2005; Lee
et al., 2003b). However, at this time, we can not fully rule
out other possible mechanisms acting in parallel or in
conjunction with AMPK signaling to mediate the life-
span-extending effects of DOG exposure.
Recently, two candidate genes have been identified that
mediate the effects of food restriction in C. elegans, the
neuron-localized transcription factor skn-1 and the Foxa
Figure 5. Glucose Availability Controls Life Span via Mito-
hormesis
(A) Life span of animals permanently exposed to DOG (as in Figure 1C),
to NAC, or to DOG plus NAC.C indicates untreated control nematodes;
, indicates results for animals treated with DOG only;B indicates an-
imals treated with NAC only;6 indicates animals treated with NAC and
subsequently with DOG.
(B and C) Life span of animals permanently exposed to DOG after pre-
treatment with the antioxidant ascorbic acid (vitamin C) (B) or the anti-
oxidant trolox (a vitamin E derivative) (C) alone or in conjunction with
DOG.C indicates control nematodes treated with ethanol as solvent
control;, indicates results for animals treated with DOG only and eth-
anol as solvent control;B indicates animals treated with antioxidant
only;6 indicates animals treated with the respective antioxidant com-
pound and DOG.288 Cell Metabolism 6, 280–293, October 2007 ª2007 Elsevier Itranscription factor family ortholog pha-4 (Bishop and
Guarente, 2007; Panowski et al., 2007). Clearly, more
research is necessary to further dissect the mechanistic
bases of different models of nutrient restriction, including
DOG-mediated glucose restriction, mechanically im-
paired strains such as eat-2 (Lakowski and Hekimi,
1998), dilution or complete removal of bacterial food
source (Kaeberlein et al., 2006; Klass, 1977), axenic
growth (Houthoofd et al., 2002a), and possibly others.
While calorie restriction is generally accepted to extend
life span in a variety of model organisms (Ingram et al.,
2006; Sinclair, 2005; Weindruch and Walford, 1988) and
to exert health-promoting metabolic alterations in humans
(Heilbronn et al., 2006), the underlying mechanisms are
a matter of fierce debate (Kaeberlein et al., 2005; Lin
et al., 2002; Sinclair et al., 2006). One line of evidence sug-
gests that downregulation of mitochondrial metabolism
causes decreased formation of ROS (Harman, 1956),
a mandatory by-product of mitochondrial electron transfer
(Dro¨ge, 2002; Rea and Johnson, 2003). This hypothesis is
essentially a modernized version of the ‘‘rate of living’’ the-
ory (Pearl, 1928), which in later years focused on detri-
mental effects of ROS (Harman, 1956). The other and
conflicting line of evidence suggests that induction of mi-
tochondrial metabolism might induce a positive response
to increased formation of ROS and other stressors, lead-
ing to a secondary, i.e., hormetic (Southam and Ehrlich,
1943), increase in stress defense and cumulating in re-
duced net stress levels (Houthoofd et al., 2002b; Johnson
et al., 2002; Kharade et al., 2005; Sinclair, 2005; Vanflete-
ren, 1993; Zarse et al., 2007).
Of potential interest in further defining the role of ROS-
mediated signaling in longevity are the well-established
findings that inactivation of genes encoding proteins local-
ized to the mitochondria can extend life span (Lee et al.,
2003b). Although respiration is generally decreased in
these strains, oxidative stress defense is often found to
be activated, suggesting—on a hypothetical basis in re-
gards to these strains, but in full congruence with our find-
ings—that a primary deregulation of ROS formation might
induce ROS defense and finally increase life expectancy.
Notably, ROS production has recently been quantified in
isolated mitochondria derived from the long-lived daf-2
mutant strain (Brys et al., 2007). In full accordance with
our findings, the authors observed elevated ROS forma-
tion in this strain and hypothesized ROS-induced hormetic
effects as a possible mechanism of action leading to in-
creased stress resistance and, ultimately, extended life
expectancy. On a speculative basis, our current obser-
vations together with the latter findings in daf-2 mutants
suggest a generalized ROS-dependent signaling pattern
that might apply to the vast majority of long-lived mutants.
Future research is clearly warranted to resolve issues of
a more generalized role of increased mitochondrial me-
tabolism in extending longevity.
Lastly, it should be noted that increasing the cellular
uptake of glucose is a fundamental pharmacological con-
cept in treatment of human type 2 diabetes. While cellular
glucose uptake is efficiently promoted by activation of thenc.
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porter GLUT4, disruption of this cascade has been shown
to extend life span in many organisms, including C. ele-
gans (Kenyon et al., 1993) and mice (Blu¨her et al., 2003;
Taguchi et al., 2007). In light of our findings, the current
body of evidence tentatively calls into question the effi-
cacy of increasing cellular glucose uptake in diabetics
and suggests that other methods of lowering blood glu-
cose (Isaji, 2007; Wright et al., 2007) may be preferable
to achieve normal life expectancy in human type 2 diabe-
tes patients.
In summary, our findings suggest that nutritional inter-
ventions, and specifically reduction of glucose uptake
and metabolism, may extend life span in an AAK-2-depen-
dent fashion due to increased respiration causing a ROS-
dependent induction of stress resistance (Figure 6). These
findings, supported by recent epidemiological findings in
humans (Bjelakovic et al., 2007), tentatively suggest that
interventions aimed at decreasing ROS formation do not
necessarily promote longevity and may rather reduce life
span in multicellular eukaryotes.
EXPERIMENTAL PROCEDURES
Nematodes
The strains used in this study were wild-type Bristol N2, aak-2(ok524),
sir2.1(ok434), and rrf-3(pk1426);sir2.1(ok434). All strains were ob-
tained from the Caenorhabditis Genetics Center (University of Minne-
sota). Nematodes were grown and maintained on NGM agar plates as
described previously (Brenner, 1974; Zarse et al., 2007). All experi-
ments were performed at 20C. C. elegans stocks and prefertile
animals were maintained on OP50 bacteria, while all experiments
Figure 6. Nutritional Regulation of Life Span byMitochondrial
Hormesis in Response to Increased Oxidative Stress
Reduced availability of glucose induces mitochondrial respiration via
AAK-2/AMPK. Increased respiration causes increased ROS formation,
leading to mitohormetically increased catalase activity and stress
resistance, cumulating in extension of life expectancy. Inversely,
increased availability of glucose reduces mitochondrial activity, de-
creasing life span in nematodes.Cell Mwere performed with the streptomycin-resistant strain OP50-i as
food source and with 200 mg/ml streptomycin added to the plates to
prevent bacterial contamination except where explicitly stated other-
wise. Plates containing experimental treatments were prepared from
the same batch of NGM agar as the control plates except that the re-
spective chemical was added to a final concentration of 5 mM from
a sterile 0.5 M stock solution for DOG and to final concentrations of
5 and 50 mM from a 1 M aqueous stock for D-glucose. NAC was
used at a final concentration of 5 mM from a 0.5 M aqueous stock.
Ascorbic acid was used at a final concentration of 5 mM and the
a-tocopherol derivative trolox was used at a final concentration of
100 mM (all from Sigma-Aldrich), using agar plates containing a final
concentration of 17 mM ethanol (dilution 1:1000) for both ascorbic
acid and a-tocopherol. It should be noted that ethanol appears to
decrease C. elegans life span (compare NAC [no ethanol] with vitamin
C/trolox [17 mM ethanol] in Figures 5A–5C). Animals were exposed to
the antioxidants from the day of hatching in all experiments. For in-
stance, short-term treatment with NAC lasted for 9 days in toto, while
short-term treatment with DOG lasted for 6 days after initiation in the
young adult stage. For all experiments involving high glucose concen-
trations, growth-arrested bacteria were employed as food source. To
efficiently inhibit bacterial growth, 1000 mg/ml ampicillin was added to
a fresh liquid culture of OP50, and bacteria were incubated for at least
5 hr. Bacteria were centrifuged and washed once with S buffer as de-
scribed previously (Zarse et al., 2007). After recentrifugation, bacteria
were kept frozen as pellets until use. Pellets were thawed and resus-
pended in one-tenth of the original culture volume with S buffer prior
to use and were streaked onto agar plates containing 100 mg/ml ampi-
cillin and 200 mg/ml streptomycin at least 24 hr before nematodes were
placed onto the plates.
Fertility Assays
To determine fertility of nematodes, ten animals at the beginning of the
egg-laying period were placed on NGM plates with or without DOG
and were removed after an incubation period of 12 hr. Offspring
were allowed to develop for 48 hr, and infertile eggs and hatched nem-
atodes were quantified.
NBDG Staining
Staining with the fluorescent compound 2-(N-(7-nitrobenz-2-oxa-
1,3-diazol-4-yl)amino)-2-deoxyglucose (NBDG) (Invitrogen) was per-
formed in live animals. A stock of 0.1 mM NBDG in DMSO was diluted
1:500 in M9 buffer to obtain a final concentration of 200 mM. Young
adult nematodes were washed off of a plate with M9 and washed three
times before resuspending in the NBDG solution. After 60–90 min of
staining, animals were briefly centrifuged and washed three times
with 15 ml M9 without NBDG to remove all dye that was not incorpo-
rated into the nematodes. Animals were mounted on microscope
slides covered with 1% agarose gel (w/v) in a small drop of 5 mM leva-
misol (Sigma-Aldrich) for anesthesia and covered with a coverslip.
Confocal photographs were taken with a Zeiss LSM 410 inverted
laser scanning microscope connected to a Zeiss Axiovert 100 micro-
scope. Magnification was 200-fold at an excitation wavelength of
488 nm and an emitted fluorescence wavelength ranging from 530 to
585 nm. Display items are representative for a series of photographs
taken of stained and nonstained animals. All photographs were taken
with identical settings to ensure comparability.
Life-Span Assays
Life-span analysis was carried out according to standard protocols
(Kenyon et al., 1993; Zarse et al., 2007). Briefly, to obtain a synchro-
nously growing population, eggs were prepared by treating a popula-
tion ofC. elegans with hypochlorite/NaOH solution and transferring the
resulting eggs to NGM agar plates covered with E. coli strain OP50. At
the prefertile young adult stage, 100 to 150 animals were transferred to
NGM plates (with or without DOG) containing 200 mg/ml streptomycin
that had been previously covered with the streptomycin-resistant bac-
terial strain OP50-i. This time point also represented the first day ofetabolism 6, 280–293, October 2007 ª2007 Elsevier Inc. 289
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tially suggested by Garigan et al., 2002; Wilson et al., 2006), bacteria
and NGM plates were additionally treated with ampicillin as described
above. Nematodes were transferred to fresh plates daily during the
progeny production period and after that were transferred every sec-
ond to third day but monitored daily for dead animals. Nematodes
that did not respond to gentle prodding and displayed no pharyngeal
pumping were scored as dead. Animals that crawled off the plate or
died due to internal hatching or protrusion of the gonads through the
vulva were censored. Censoring describes an event where partial in-
formation on the life span of an individual animal is lost as a conse-
quence of premature death. Thus, censored animals were included
in statistical analysis only until the day of the censoring event. Repli-
cates were carried out as indicated in Table 1, column 4. No censoring
was applied in Figure 1B.
Fat Content Analyses
Eggs were prepared as above and allowed to hatch overnight in M9
buffer to obtain a highly synchronous population of L1-stage animals.
Nematodes were then shifted to NGM plates covered with E. coli
OP50, allowed to grow until the L4 stage, and transferred to plates
containing 25 mM 5-fluoro-20-deoxyuridine (Sigma-Aldrich) to prevent
progeny formation. After an incubation of 16 hr, animals were trans-
ferred to the respective treatment groups and harvested at the indi-
cated time points by three consecutive washes in ice-cold M9 buffer
to separate nematodes from bacteria. Nematodes were flash frozen
in liquid nitrogen and stored at80C until further processing. Approx-
imately 25 mg was weighed and ground in a nitrogen-chilled mortar to-
gether with 250 ml of frozen phosphate buffer. The frozen material was
gathered in a reaction tube and kept on ice. Extracts were sonicated
three times and centrifuged for 7 min at 12,000 3 g to clear the lysate
off of insoluble matter. Fat content was determined with a commercially
available triglyceride determination kit (Sigma-Aldrich) as previously
described (Ristow et al., 2000) and normalized to protein content,
which was determined according to the Bradford (1976) method. For
each treatment condition and time point indicated, at least two inde-
pendently generated biological samples were obtained, with double
preparations of lysates from each sample and double measurements
for every preparation.
Respiration Assays
Oxygen consumption rates were measured using a DW1/AD Clark-
type oxygen electrode (Hansatech) as previously described (Lee
et al., 2003a; Zarse et al., 2007). Age-synchronized animals were ob-
tained as described above. Approximately 2000 nematodes were
plated on NGM plates containing the corresponding treatment and
200 mg/ml streptomycin and covered with E. coli OP50-i. For every
time point, at least two independent experiments were performed
comprising at least three replicates per experiment and time point.
At the time of measurement, animals were washed three times with
M9 buffer and resuspended in 2 ml of M9 buffer. One milliliter aliquots
were transferred into the chamber, and respiration was measured at
20C for at least 10 min. Samples were carefully recovered from the
chamber, centrifuged, and homogenized in a Dounce-type homoge-
nizer (Homgen Plus, Schu¨tt Labortechnik) for 30 s at 3000 rpm. After
centrifugation at 8000 3 g for 5 min, the supernatant was removed
and used for protein quantification by the Bradford (1976) method.
RNA Interference
RNAi was induced as described (Oh et al., 2006; Zarse et al., 2007)
according to standard protocols. For the life-span and respiration as-
says, slight modifications were applied: Animals were fed with RNAi
bacteria from the day of hatching, and thus the age of the population
tested in the respiration assay corresponds to that of the 48 hr DOG
treatment groups. In addition, streptomycin in the plates was replaced
by 100 mg/ml ampicillin, as the bacterial strain HT115 used for the RNAi
feeding protocol contained an ampicillin-resistance plasmid. As a con-
trol, we employed HT115 bacteria harboring the L4440 plasmid with-290 Cell Metabolism 6, 280–293, October 2007 ª2007 Elsevierout insertion as described before (Zarse et al., 2007). For induction
of RNAi directed against glucose phosphate isomerase (gpi-1) gene
transcripts, an RNAi plasmid described previously was used (Hansen
et al., 2005; Kamath and Ahringer, 2003; Kamath et al., 2003). To en-
sure the presence of proper RNAi effects, the plasmid pLT61.1 from
the Fire Lab Vector Kit, which causes a strong twitching phenotype
in affected animals, was used as a parallel control in all RNAi experi-
ments.
Stress Resistance Assays
Stress resistance was assayed by maintaining nematodes for 6 days,
until progeny production ceased, on DOG or control plates. The 6 day
treatment appeared necessary, as most animals died due to internal
hatching if the stressor was applied earlier throughout the egg-laying
period. After 6 days, nematodes were transferred to plates containing
either 50 mM paraquat or 1 mM sodium azide (both from Sigma-Al-
drich) in addition to DOG where applicable. Dead animals were scored
as described above. NAC was applied similarly at a final concentration
of 5 mM. Nematodes were maintained on NAC during development
and during treatment with DOG (from L4 onward) before transferring
to NGM plates containing paraquat or sodium azide in addition to
the primary stressor where applicable.
Quantification of ROS Formation
ROS formation was quantified according to a modified protocol em-
ploying the membrane-permeable nonfluorescent dye 2,7-dichlorodi-
hydrofluorescein-diacetate (H2-DCF-DA) (Sigma-Aldrich) (Kampko¨tter
et al., 2007). Upon entering the cell, H2-DCF-DA is deacetylated and
becomes membrane impermeable. H2-DCF fluoresces upon oxidation
to 2,7-dichlorofluorescein (DCF) by ROS. Briefly, animals were main-
tained and treated as described above. After 48 hr of exposure to
the respective compounds, animals were washed off of the plates
with cold M9 buffer. Bacteria were removed by three repeated washes
and subsequent centrifugation at low speed. Animals were resus-
pended in M9 buffer, and a 50 ml volume of the suspension was pipet-
ted in four replicates into the wells of a 96-well plate with opaque walls
and transparent bottom and allowed to equilibrate to room tempera-
ture. In the meantime, a fresh 100 mM H2-DCF-DA solution from
a 100 mM stock solution in DMSO was prepared in M9 buffer, and
a volume of 50 ml was pipetted to the suspensions, resulting in a final
concentration of 50 mM. On each plate, control wells containing nem-
atodes from each treatment without H2-DCF-DA and wells containing
H2-DCF-DA without animals were prepared in parallel. Immediately af-
ter addition of H2-DCF-DA, basal fluorescence was measured in a mi-
croplate reader at excitation/emission wavelengths of 485 and 520 nm.
Plates were kept on a shaker at 20C for 60 min and were measured
under conditions equivalent to before. The initial fluorescence and
the fluorescence signals of the control wells were subtracted from
the corresponding signals of each well after the second measurement.
One milliliter of the initial animal suspension from each sample was
centrifuged, and the pellets were kept at – 80C for later protein quan-
tification to normalize the fluorescence signal. Assays were performed
in independent duplicates.
Protein Analyses
Nematodes were washed three times with ice-cold M9 buffer as
above, and pellets were shock frozen in liquid nitrogen. Protein extrac-
tion and western blot were performed as described previously (Schulz
et al., 2006) except for minor adaptations due to the nature of the sam-
ple. Frozen pellets were ground in a nitrogen-chilled mortar and
gathered in phosphate buffer containing protease and phosphatase
inhibitors, Complete protease inhibitor cocktail (Roche), 2 mM sodium
fluoride, 2 mM sodium orthovanadate, 1 mM PMSF, and 2 mM EDTA
(all from Sigma-Aldrich). Extracts were sonicated three times and
centrifuged for 7 min at 12,000 3 g to clear the lysate off of insoluble
matter. Supernatants were used for protein quantification, and a por-
tion was boiled in sample buffer and applied for SDS-PAGE. Anti-
bodies against basal and phosphorylated (Ser172) AMPK (both fromInc.
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used. Antibody raised against basal AMPK gave no specific signal
on protein extracts from C. elegans.
RNA Extraction and RNA Array Analyses
Animals were treated as described above for fat content analyses.
Adult animals were placed on plates containing 5-fluoro-20-deoxyuri-
dine and the indicated treatment for 48 hr. Three independent repli-
cates were prepared for both control- and DOG-treated animals (i.e.,
6 samples in total). RNA was extracted from nematode samples ac-
cording to the TRIzol method (Invitrogen) as described (Thierbach
et al., 2005) and according to the manufacturer’s instructions. Fifty mil-
ligrams of frozen nematode sample was used for each extraction. RNA
was subsequently loaded onto an RNA binding column (QIAGEN) to
remove contaminating genomic DNA and proteins before further pro-
cessing. Total RNA content was assayed, and equal amounts of RNA
were used for hybridization. For transcript-level analysis, the Affyme-
trix GeneChip C. elegans Genome Array was used according to the
manufacturer’s instructions. Analysis of the presented data was per-
formed with Affymetrix GCOS 1.4 software by comparing means of
signal intensities from RNA samples derived from control- and DOG-
treated animals. Genes that displayed regulation in either direction
were assembled and assigned a molecular function where possible
by searching the Wormbase databank (http://www.wormbase.org/)
for detailed information on the specific Affymetrix probe set identity
numbers. Ratios for transcript-level regulation as control- over DOG-
treated signal intensities were obtained to illustrate the extent of regu-
lation (Affymetrix GCOS 1.4 software; threshold for downregulation
was set to 1.50 and for upregulation to 0.66). As individual transcripts
are represented by a set of different probes on the chip, transcripts
were only considered to be regulated when at least two-thirds of
probes for the same transcript displayed similar regulation. A subset
of genes was grouped manually where applicable to facilitate inter-
pretation of the data (Table S1); the complete set of genes is listed in
Table S2.
Activity Assay for CAT, SOD, and GPX
Enzyme activities were assayed by employing commercially available
kits (CAT and GPX, EMD Bioscience/Merck Biosciences; SOD, Sigma-
Aldrich) and processed according to the respective manufacturers’
instructions. For each time point and treatment, at least three indepen-
dent samples were prepared at different days and extracted for further
measurements. Extracts were measured in double determinations.
Briefly, approximately 25 mg of frozen nematode sample was homog-
enized as described above in 50 mM potassium phosphate buffer
containing 1 mM EDTA (pH 7.0), sonicated, and cleared by centrifuga-
tion. Supernatant samples were diluted 1:3 for CAT and SOD or used
undiluted for GPX and assayed for enzyme activity.
[14C]Glucose Oxidation
Uniformly labeled [14C]D-glucose was purchased from GE Healthcare.
Specific activity of the batch used was 281 mCi/mmol. Animals were
maintained as described above on plates containing FUDR and the re-
spective treatment for 48 hr. Equal numbers of animals were placed on
each plate when treatment was initiated. After collection and three
subsequent washes in S medium, worm pellets were resuspended in
the incubation buffer. Two milliliters of the suspension was transferred
to 4 cm Petri dishes. The latter were placed in 10 cm Petri dishes
together with a second 4 cm Petri dish containing 1 ml of 0.1N KOH
solution to trap CO2 as described previously (Ristow et al., 2000).
Hence, each 10 cm dish contained two 4 cm dishes, one carrying nem-
atodes and the other containing KOH. As a substrate, labeled glucose
was added to a final concentration of 35 mM U-[14C]D-glucose (10 mCi/
ml) in the nematode suspension. Nonradioactive glucose or DOG was
added to a final concentration of 5 mM to the control samples or the
samples pretreated with DOG, respectively. The 10 cm Petri dishes
were covered, sealed with Parafilm in an air-tight manner, and incu-
bated at 20C for 60 min. Subsequently, an aliquot of 900 ml of KOHCell Mwas immersed in 10 ml of scintillation fluid and placed in a liquid scin-
tillation counter (Beckman LS 6000, Global Medical Instrumentation,
Inc.) to quantify the amount of trapped 14CO2 as described previously
(Ristow et al., 2000).
Quantification of ATP
Animals were treated and samples were obtained as described above
for fat content analyses. Quantification of ATP followed standard pro-
tocols for animal samples. Briefly, worm lysates were prepared as
above by grinding approximately 20 mg of sample in a nitrogen-chilled
mortar and collection in perchloric acid solution (0.6 M in 1 mM EGTA).
Precipitated proteins were separated by centrifugation after 30 min in-
cubation on ice and redissolved in 1 M sodium hydroxide solution for
protein quantification after drying. The supernatant was adjusted to
neutral pH with 3 M potassium hydroxide/potassium chloride solution
and incubated for 10 min on ice. Precipitated salts were removed by
centrifugation, and the supernatant was stored for later ATP quantifi-
cation at 80C. ATP content was determined as described previously
(Ristow et al., 2000) by applying a commercially available assay kit
(Sigma-Aldrich). Three independent samples were prepared for each
treatment and time point, and double extractions were performed for
each sample. Each extract was assayed for ATP content in duplicate.
Statistical Analyses
Statistical analyses for the fertility, fat content, oxygen consumption,
and enzyme activity assays were performed by Student’s t test after
testing for equal distribution of the data and equal variances within
the data set. For comparing significant distributions between different
groups in the life-span assays and stress resistance assays, statistical
calculations were carried out using the log-rank test. All calculations
were performed using Microsoft Office Excel 2003 and SPSS version
13.0 as described previously (Schulz et al., 2006; Zarse et al., 2007).
Experiments were performed in triplicate except where stated other-
wise. Error measures were calculated from the variability of the inde-
pendently prepared biological samples of the same treatment group
where applicable. Differences were considered statistically significant
at p < 0.05, thereby indicating a probability of error lower than 5%.
Supplemental Data
Supplemental Data include two figures and two tables and can be
found with this article online at http://www.cellmetabolism.org/cgi/
content/full/6/4/280/DC1/.
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